Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject

Alimohammadi A, Holeksa J, Thiam A, Truong D, Conway B. Real-world efficacy of direct-acting antiviral therapy for HCV infection affecting people who inject drugs delivered in a multidisciplinary setting. Open Forum Infectious Diseases. 2018; 5(6).


Full text: https://doi.org/10.1093/ofid/ofy120


Many clinicians and insurance providers are reluctant to embrace recent guidelines identifying people who inject drugs (PWID) as a priority population to receive hepatitis C virus (HCV) treatment. The aim of this study was to evaluate the efficacy of direct-acting antiviral (DAA) HCV therapy in a real-world population comprised predominantly of PWID.

© 2020 by Vancouver Infectious Diseases Centre. 

logo%20png_edited.png